Skip to main content
Home
Drug Metabolic Roadmap (2024 update)
★
Drug Metabolic Roadmap
★
Drug Metabolite
★
Metabolic Reaction
DME Interactome
Microbiome-DME Interaction
Host Protein-DME Interaction
Xenobiotics-DME Interaction
Download
Help
Drug Information
Drug General Information
Drug ID
D06AJP
Former ID
DNC009426
Drug Name
(E)-5-(3-Chlorostyryl)isatin
Drug Type
Small molecular drug
Indication
Discovery agent
Investigative
[
530056
]
Formula
C16H10ClNO2
Canonical SMILES
C1=CC(=CC(=C1)Cl)C=CC2=CC3=C(C=C2)NC(=O)C3=O
InChI
1S/C16H10ClNO2/c17-12-3-1-2-10(8-12)4-5-11-6-7-14-13(9-11)15(19)16(20)18-14/h1-9H,(H,18,19,20)/b5-4+
InChIKey
ZKYUNESJTCRBIF-SNAWJCMRSA-N
PubChem Compound ID
44575103
Target and Pathway
Target(s)
Amine oxidase [flavin-containing] A
Target Info
Inhibitor
[
530056
]
Amine oxidase [flavin-containing] B
Target Info
Inhibitor
[
530056
]
BioCyc Pathway
Superpathway of tryptophan utilization
Dopamine degradation
Putrescine degradation III
Noradrenaline and adrenaline degradation
Serotonin degradation
Superpathway of melatonin degradation
Melatonin degradation IIPWY66-401:Superpathway of tryptophan utilization
Tryptophan degradation via tryptamine
KEGG Pathway
Glycine, serine and threonine metabolism
Arginine and proline metabolism
Histidine metabolism
Tyrosine metabolism
Phenylalanine metabolism
Tryptophan metabolism
Drug metabolism - cytochrome P450
Metabolic pathways
Serotonergic synapse
Dopaminergic synapse
Cocaine addiction
Amphetamine addiction
Alcoholismhsa00260:Glycine, serine and threonine metabolism
Alcoholism
NetPath Pathway
IL4 Signaling Pathway
PANTHER Pathway
Adrenaline and noradrenaline biosynthesis
5-Hydroxytryptamine degredation
Dopamine receptor mediated signaling pathwayP00001:Adrenaline and noradrenaline biosynthesis
Dopamine receptor mediated signaling pathway
Pathway Interaction Database
Alpha-synuclein signaling
PathWhiz Pathway
Histidine Metabolism
Tyrosine Metabolism
Glycine and Serine Metabolism
Reactome
Norepinephrine Neurotransmitter Release Cycle
WikiPathways
SIDS Susceptibility Pathways
Biogenic Amine Synthesis
Oxidative Stress
Dopamine metabolism
Phase 1 - Functionalization of compounds
Neurotransmitter Release Cycle
Neurotransmitter Clearance In The Synaptic Cleft
Serotonin Transporter ActivityWP465:Tryptophan metabolism
References
Ref 530056
Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13. Epub 2009 Mar 14.Inhibition of monoamine oxidase by (E)-styrylisatin analogues.
Ref 530056
Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13. Epub 2009 Mar 14.Inhibition of monoamine oxidase by (E)-styrylisatin analogues.
If you find any error in data or bug in web service, please kindly report it to
Dr. Yin
and
Dr. Li
.